Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
42
Views
3
CrossRef citations to date
0
Altmetric
Letter

The renoprotective effects of sulodexide

Rik HG Olde EngberinkDepartment of Internal Medicine, Section of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
&
Liffert VogtDepartment of Internal Medicine, Section of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsCorrespondence[email protected]
Pages 1233-1234 | Published online: 22 Mar 2016

References

  • LiRXingJMuXSulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature reviewDrug Des Devel Ther2015962756283
  • BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type2 diabetes and nephropathyN Engl J Med200134586186911565518
  • LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin–receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med200134585186011565517
  • RuggenentiPFassiAIlievaAPPreventing microalbuminuria in type 2 diabetesN Engl J Med20043511941195115516697
  • ParvingHHLehnertHBrochner-MortensenJGomisRAndersenSArnerPThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med200134587087811565519
  • LewisEJHunsickerLGBainRPRohdeRDThe effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupN Engl J Med1993329145614628413456
  • de ZeeuwDRemuzziGParvingHHProteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALKidney Int2004652309232015149345
  • LewisEJLewisJBGreeneTCollaborative Study GroupSulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trialAm J Kidney Dis20115872973621872376
  • PackhamDKWolfeRReutensATCollaborative Study GroupSulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyJ Am Soc Nephrol20122312313022034636
  • DedovIShestakovaMVorontzovAPalazziniEA randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathyNephrol Dial Transplant19971211229523009394314
  • GambaroGKinalskaIOksaAOral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trialJ Am Soc Nephrol20021361615162512039991
  • Olde EngberinkRHRorijeNMLambers HeerspinkHJDe ZeeuwDvan den BornBJVogtLThe blood pressure lowering potential of sulodexide – a systematic review and meta-analysisBr J Clin Pharmacol20158061245125326184982

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.